Metabolic control and chronic complications during a 3-year follow-up period in a cohort of type 2 diabetic patients attended in primary care in the Community of Madrid (Spain)

被引:1
|
作者
Arrieta, Francisco [1 ,2 ]
Pinera, Marbella [3 ]
Iglesias, Pedro [1 ,2 ]
Nogales, Pedro [3 ]
Angel Salinero-Fort, Miguel [4 ]
Carlos Abanades, Juan [5 ]
Ignacio Botella-Carretero, Jose [1 ,2 ]
Calanas, Alfonso [1 ]
Antonio Balsa, Jose [1 ,2 ]
Zamarron, Isabel [1 ,2 ]
Rovira, Adela [6 ]
Vazquez, Clotilde [1 ,2 ]
机构
[1] Hosp Ramon & Cajal, Dept Endocrinol & Nutr, Unit Clin Nutr & Obes, E-28034 Madrid, Spain
[2] IRYCIS, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain
[3] Ctr Salud, Med Familia, Madrid, Spain
[4] Hosp Carlos III, Serv Madrileno Salud, Fdn Invest Biomed, Madrid, Spain
[5] Comunidad Madrid, Gerencia Invest & Docencia Atenc Primaria, Madrid, Spain
[6] Hosp Fdn Jimenez Diaz Capio, Madrid, Spain
来源
ENDOCRINOLOGIA Y NUTRICION | 2014年 / 61卷 / 01期
关键词
Type; 2; diabetes; Incidence; Chronic complications; Primary care; Metabolic control; GLYCEMIC CONTROL; RISK-FACTORS; HYPERGLYCEMIA; ASSOCIATION; PREVALENCE; MORTALITY; MELLITUS; REVERSAL;
D O I
10.1016/j.endoen.2013.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Our aim was to analyze both metabolic control and chronic complications of type 2 diabetes mellitus (T2D) patients regularly attended in primary care during a 3 years of follow-up in the Community of Madrid (Spain). Methods: From 2007 to 2010 we prospectively included 3268 patients with T2D attended by 153 primary care physicians from 51 family health centers. An prospective cohort study with annual evaluation over 3 years to the same population was performed. We measured the goals of control in diabetic patients and the incidence of chronic complications of diabetes during the study period. Results: A significant decrease in serum glucose levels (143 +/- 42 mg/dl vs 137 +/- 43 mg/dl, p<0.00), HbA1c (7.09 +/- 1.2% vs 7.02 +/- 1.2%, p<0.00), total cholesterol (191.4 +/- 38 mg/dl vs 181.5 36 mg/dl, p<0.00), LDL cholesterol (114.7 +/- 31 mg/dl vs 105.5 30 mg/dl, p<0.00) and triglyceride levels (144.5 +/- 93 mg/dl vs 138 +/- 84 mg/dl, p<0.00) during study period was documented. On the contrary, a significant elevation in HDL cholesterol levels was observed (49.2 +/- 14 mg/dl vs 49.9 16 mg/dl, p< 0.00). The incidence of diabetic complications throughout the study period was low, with a incidence of coronary heart disease of 6.2%, peripheral arterial disease 3%, ischemic stroke 2.8%, diabetic foot 11.2%, nephropathy 5.9%, retinopathy 4.5%, and neuropathy 3%. Conclusion: Metabolic control in T2D patients attended in primary care in the Community of Madrid throughout 3 years is adequate and is accompanied by low percent of chronic diabetic complications during this period of follow-up. (C) 2013 SEEN. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [31] THE DEVELOPMENT OF AIDS OR AIDS-RELATED CONDITIONS IN A COHORT OF HIV ANTIBODY-POSITIVE HOMOSEXUAL MEN DURING A 3-YEAR FOLLOW-UP PERIOD
    PEDERSEN, C
    KOLBY, P
    SINDRUP, J
    GAUB, J
    ULLMAN, S
    GERSTOFT, J
    LINDHARDT, BO
    DICKMEISS, E
    JOURNAL OF INTERNAL MEDICINE, 1989, 225 (06) : 403 - 409
  • [32] Medical Therapy, Surgery and Hospitalization Rates During the 2-and 3-Year Follow-Up of the 2011 ECCO-EpiCom Cohort
    Vegh, Zsuzsanna
    Burisch, Johan M.
    Kaimakliotis, John
    Duricova, Dana
    Carlsen, Katrine
    Nielsen, Kri R.
    Christodoulou, Dimitrios K.
    Lakatos, Laszlo
    Odes, Selwyn H.
    D'Inca, Renata
    Kiudelis, Gediminas
    Turcan, Svetlana
    Magro, Fernando
    Goldis, Adrian
    Hernandez, Vicent
    Bell, Sally
    Langholz, Ebbe
    Munkholm, Pia
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2016, 150 (04) : S785 - S785
  • [33] Medical therapy, surgery and hospitalisation rates during the 2-and 3-year follow-up of the 2011 ECCO-EpiCom cohort
    Vegh, Z.
    Burisch, J.
    Kaimakliotis, I.
    Duricova, D.
    Carlsen, K.
    Nielsen, K. R.
    Christodoulou, D. K.
    Lakatos, L.
    Odes, S.
    D'Inca, R.
    Kiudelis, G.
    Turcan, S.
    Magro, F.
    Goldis, A.
    Hernandez, V.
    Bell, S.
    Langholz, E.
    Munkholm, P.
    Lakatos, P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S442 - S443
  • [34] Macular maps of fluorescein leakage during a 3-year follow-up in patients with type 2 diabetes Mellitus and mild non-proliferative retinopathy
    Duarte, LG
    Lobo, CL
    Bernardes, RC
    Soares, MA
    Figueira, JP
    Abreu, JF
    Cunha-Vaz, JG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U424 - U424
  • [35] Pancreas trasnplant alone (PTA) in type 1 diabetic patients (T1DM): A 3-yr metabolic and diabetic complications follow-up
    Giannarelli, Rosa
    Coppelli, Alberto
    Vistoli, Fabio
    Tedeschi, Anna
    Piaggesi, Alberto
    Boggi, Ugo
    Mosca, Franco
    Del Prato, Stefano
    Marchetti, Piero
    DIABETES, 2006, 55 : A445 - A445
  • [36] THE CONTROL OF BLOOD GLUCOSE AND COMPLICATIONS AMONG TYPE 2 DIABETES MELLITUS PATIENTS BASED ON THE DYNAMIC CHANGES OF DIETARY INTAKE DURING THE FOLLOW-UP SURVEY PERIOD
    Li Yong
    Fan Rui
    Xu Meihong
    Wang Junbo
    ANNALS OF NUTRITION AND METABOLISM, 2017, 71 : 901 - 901
  • [37] Mesenchymal stromal cells therapy alone does not lead to the complete restoration of the skin parameters in diabetic foot patients within a 3-year follow-up period
    Maksimova, Nadezhda, V
    Michenko, Anna, V
    Krasilnikova, Olga A.
    Klabukov, Ilya D.
    Gadaev, Igor Yu
    Krasheninnikov, Michael E.
    Belkov, Pavel A.
    Lyundup, Aleksey, V
    BIOIMPACTS, 2022, 12 (01) : 51 - 55
  • [38] Follow-up of patients with type 2 diabetes during the COVID-19 pandemic: A multicentre study in Primary Care
    Fernandez, F. Cuevas
    Lopez, O. T. Gomez
    Espineira, M. Dorta
    Villalba, S. Farrais
    Leon, A. Cabrera de
    Aguirre-Jaime, Armando
    MEDICINA DE FAMILIA-SEMERGEN, 2023, 49 (08):
  • [39] Five-Year Follow-Up of Diabetic Complications and Geriatric Alterations in French Older Patients with Type 2 Diabetes According to Treatment Modalities: The Observational Prospective GERODIAB Cohort
    Doucet, Jean
    Guerin, Olivia
    Hilbert, Caroline
    Bordier, Lyse
    Wils, Julien
    Benichou, Jacques
    Bauduceau, Bernard
    AAPS PHARMSCITECH, 2023, 24 (07): : 1027 - 1036
  • [40] Five-Year Follow-Up of Diabetic Complications and Geriatric Alterations in French Older Patients with Type 2 Diabetes According to Treatment Modalities: The Observational Prospective GERODIAB Cohort
    Jean Doucet
    Olivia Guérin
    Caroline Hilbert
    Lyse Bordier
    Julien Wils
    Jacques Bénichou
    Bernard Bauduceau
    Drugs & Aging, 2023, 40 : 1027 - 1036